Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GUASCH, A.
Right arrow Articles by ELSAS, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GUASCH, A.
Right arrow Articles by ELSAS, L. J.
J Am Soc Nephrol 10:1014-1019, 1999
© 1999 American Society of Nephrology


REGULAR ARTICLES

Evidence that Microdeletions in the {alpha} Globin Gene Protect Against the Development of Sickle Cell Glomerulopathy in Humans

ANTONIO GUASCH*, CARLOS F. ZAYAS*, JAMES R. ECKMAN{ddagger}, KASINATHAN MURALIDHARAN{dagger}, WEI ZHANG{dagger} and LOUIS J. ELSAS{dagger}

* Renal Division, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
{dagger} Division of Medical Genetics, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
{ddagger} Georgia National Institutes of Health Sickle Cell Center, Emory University School of Medicine, Atlanta, Georgia.

Correspondence to Dr. Antonio Guasch, Renal Division, Room 338, Emory University School of Medicine, 1639 Pierce Drive, Atlanta, GA 30322. Phone: 404-727-2525; Fax: 404-727-3425; E-mail: aguasch{at}emory.edu

Abstract. There is a large variability in the severity of the clinical manifestations of sickle cell anemia (SSA), including renal involvement. Haplotypes in the ß-globin gene cluster associated with the geographical origin of the sickle mutation, as well as microdeletions in the {alpha}-globin genes, could provide an epigenetic influence on the heterogeneous outcome in SSA. It has been determined that the cause of progressive renal insufficiency in SSA is a glomerulopathy, clinically detected by the presence of macroalbuminuria (albumin excretion rate >300 mg/g creatinine). To investigate the role of the {alpha}-globin gene microdeletion and ß-globin gene cluster haplotypes on the degree of glomerular involvement, 76 adult SSA patients (hemoglobin SS) were studied to determine the relationship between these genetic markers and the development of sickle cell glomerulopathy. Macroalbuminuria was present in 22 (29%) of 76 adult SSA patients. The coinheritance of microdeletions in one or two of the four {alpha}-globin genes ({alpha}-thalassemia) was associated with a lower prevalence of macroalbuminuria (13%) versus patients with intact {alpha}-globin genes (40%, P = 0.01). By contrast, there was no association between albuminuria and ß-globin gene haplotypes (Central African Republic [CAR] versus non-CAR haplotypes). Patients with {alpha}-globin gene microdeletions had lower mean corpuscular volumes and mean corpuscular hemoglobin concentration than patients with all four {alpha} genes (86 ± 2 versus 99 ± 3 fl, and 33.9 ± 0.2 versus 34.9 ± 0.2%, respectively, P < 0.05). There were no such hematologic differences between CAR and non-CAR ß-globin haplotypes. There were no differences in duration of disease (age), hemoglobin levels, reticulocyte index, and lactate dehydrogenase levels between those with and without glomerulopathy, but the mean arterial pressure was higher (87 ± 1 mmHg) in patients with intact {alpha} gene locus versus those with microdeletions (80 ± 2 mmHg, P < 0.05). It is concluded that the coinheritance of microdeletions in the {alpha}-globin gene locus in SSA patients confers "renoprotection" by mechanisms not related to the degree of anemia or the severity of hemolysis, but could be related to a reduced mean corpuscular volume or to a lower erythrocyte hemoglobin concentration.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
A. Guasch, J. Navarrete, K. Nass, and C. F. Zayas
Glomerular Involvement in Adults with Sickle Cell Hemoglobinopathies: Prevalence and Clinical Correlates of Progressive Renal Failure
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2228 - 2235.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP